Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-17-004995
Filing Date
2017-05-22
Accepted
2017-05-22 16:32:07
Documents
58
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q mbvx10q_mar312017.htm 10-Q 718454
2 FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT ex10-1.htm EX-10.1 36613
3 INVESTOR CONSENT ex_10-2.htm EX-10.2 42104
4 FORM OF RESCISSION AGREEMENT ex_10-3.htm EX-10.3 34957
5 FORM OF LETTER AGREEMENT ex_10-4.htm EX-10.4 16764
6 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF ex31-1.htm EX-31.1 12555
7 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF ex31-2.htm EX-31.2 12773
8 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE ex32.htm EX-32 9646
  Complete submission text file 0001654954-17-004995.txt   2650351

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT mbvx-20170331.xml EX-101.INS 287050
10 XBRL TAXONOMY EXTENSION SCHEMA mbvx-20170331.xsd EX-101.SCH 24365
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mbvx-20170331_cal.xml EX-101.CAL 45958
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbvx-20170331_def.xml EX-101.DEF 74346
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbvx-20170331_lab.xml EX-101.LAB 211064
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbvx-20170331_pre.xml EX-101.PRE 163924
Mailing Address 11535 SORRENTO VALLEY ROAD SUITE 400 SAN DIEGO CA 92121
Business Address 11535 SORRENTO VALLEY ROAD SUITE 400 SAN DIEGO CA 92121 8582599405
MABVAX THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001109196 (see all company filings)

EIN.: 930987903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37861 | Film No.: 17861333
SIC: 2834 Pharmaceutical Preparations